<VariationArchive VariationID="56749" VariationName="NM_030943.4(AMN):c.14del (p.Gly5fs)" VariationType="Deletion" Accession="VCV000056749" Version="5" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="71388" VariationID="56749">
      <GeneList>
        <Gene Symbol="AMN" FullName="amnion associated transmembrane protein" GeneID="81693" HGNC_ID="HGNC:14604" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q32.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="102922663" stop="102930842" display_start="102922663" display_stop="102930842" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="103388992" stop="103397178" display_start="103388992" display_stop="103397178" Strand="+" />
          </Location>
          <OMIM>605799</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_030943.4(AMN):c.14del (p.Gly5fs)</Name>
      <CanonicalSPDI>NC_000014.9:102922699:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q32.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="102922700" stop="102922700" display_start="102922700" display_stop="102922700" variantLength="1" positionVCF="102922699" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="103389037" stop="103389037" display_start="103389037" display_stop="103389037" variantLength="1" positionVCF="103389036" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G5fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_030943.3" sequenceAccession="NM_030943" sequenceVersion="3" change="c.14delG">
            <Expression>NM_030943.3:c.14delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_642" sequenceAccession="LRG_642">
            <Expression>LRG_642:g.5047del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.103389039del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.103389039del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.102922702del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.102922702del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008276.2" sequenceAccession="NG_008276" sequenceVersion="2" change="g.5047del">
            <Expression>NG_008276.2:g.5047del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_030943.4" sequenceAccession="NM_030943" sequenceVersion="4" change="c.14del" MANESelect="true">
            <Expression>NM_030943.4:c.14del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_112205.2" sequenceAccession="NP_112205" sequenceVersion="2" change="p.Gly5fs">
            <Expression>NP_112205.2:p.Gly5fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA144407" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605799.0001" DB="OMIM" />
        <XRef Type="rs" ID="386834168" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_030943.4(AMN):c.14del (p.Gly5fs) AND Imerslund-Grasbeck syndrome type 2" Accession="RCV000005035" Version="4">
        <ClassifiedConditionList TraitSetID="1310">
          <ClassifiedCondition DB="MedGen" ID="C4016948">Imerslund-Grasbeck syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_030943.4(AMN):c.14del (p.Gly5fs) AND Imerslund-Grasbeck syndrome" Accession="RCV000050162" Version="3">
        <ClassifiedConditionList TraitSetID="1311">
          <ClassifiedCondition DB="MedGen" ID="C4551825">Imerslund-Grasbeck syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-18" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12590260</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">13852753</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22929189</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">6741523</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-10-29">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-10-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1311" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2837" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Imerslund-Gräsbeck syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Imerslund-Grasbeck syndrome</ElementValue>
                <XRef ID="MONDO:0009853" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pernicious anemia, juvenile, due to selective intestinal malabsorption of vitamin b12, with proteinuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Enterocyte cobalamin malabsorption</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Enterocyte intrinsic factor receptor, defect of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Megaloblastic anemia due to inborn errors of metabolism</ElementValue>
                <XRef ID="Megaloblastic+anemia+due+to+inborn+errors+of+metabolism/8803" DB="Genetic Alliance" />
                <XRef ID="34925000" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGA1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7006" />
                <XRef ID="7006" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="35858" DB="Orphanet" />
              <XRef ID="C4551825" DB="MedGen" />
              <XRef ID="MONDO:0009853" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS261100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1310" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10095" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Megaloblastic anemia 1, Norwegian type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Imerslund-Grasbeck syndrome type 2</ElementValue>
                <XRef ID="MONDO:0100157" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEGALOBLASTIC ANEMIA, NORWEGIAN TYPE</ElementValue>
                <XRef Type="MIM" ID="618882" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Imerslund-Gräsbeck syndrome 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IGS2</ElementValue>
                <XRef Type="MIM" ID="618882" DB="OMIM" />
              </Symbol>
              <XRef ID="C4016948" DB="MedGen" />
              <XRef ID="MONDO:0100157" DB="MONDO" />
              <XRef Type="MIM" ID="618882" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25211" SubmissionDate="2020-05-19" DateLastUpdated="2020-05-31" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="605799.0001_IMERSLUND-GRASBECK SYNDROME 2" title="AMN, 1-BP DEL, 14G_IMERSLUND-GRASBECK SYNDROME 2" />
        <ClinVarAccession Accession="SCV000025211" DateUpdated="2020-05-31" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 3 Norwegian families (families A, C, and D) with Imerslund-Grasbeck syndrome-2 (IGS2; 618882), Tanner et al. (2003) identified a homozygous 1-bp deletion (c.14delG) in exon 1 of the AMN gene, resulting in a frameshift and premature termination. The mutation, which was found by a combination of linkage analysis and candidate gene sequencing, segregated with the disorder in the families. The families had previously been reported by Imerslund (1960) and Broch et al. (1984); haplotype analysis was consistent with a shared origin of the mutation. In vitro protein expression studies showed that the c.14delG mutation greatly reduced expression of the primary 50-kD protein, but did not appear to completely abolish it, likely due to an alternative downstream start codon.</Attribute>
              <Citation>
                <ID Source="PubMed">12590260</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">13852753</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">6741523</ID>
              </Citation>
              <XRef DB="OMIM" ID="618882" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AMN" />
          </GeneList>
          <Name>AMN, 1-BP DEL, 14G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 14G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605799.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IMERSLUND-GRASBECK SYNDROME 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="131961" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS1004" />
        <ClinVarAccession Accession="SCV000082572" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">12590260</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030943.3:c.14delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Megaloblastic anemia due to inborn errors of metabolism</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="261100" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5453493" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_030943.4:c.14del|OMIM:618882" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002802967" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_030943.4:c.14del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618882" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6131254" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4920495|MedGen:C1306856" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003442719" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12590260</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22929189</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12590260</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly5Alafs*12) in the AMN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AMN are known to be pathogenic (PMID: 12590260, 22929189). This variant is present in population databases (rs746999720, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with megaloblastic anemia (PMID: 12590260). ClinVar contains an entry for this variant (Variation ID: 56749). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AMN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.103389037del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1306856" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="131961" TraitType="Disease" MappingType="Name" MappingValue="Megaloblastic anemia due to inborn errors of metabolism" MappingRef="Preferred">
        <MedGen CUI="C4551825" Name="Imerslund-Grasbeck syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5453493" TraitType="Disease" MappingType="XRef" MappingValue="618882" MappingRef="OMIM">
        <MedGen CUI="C4016948" Name="Imerslund-Grasbeck syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6131254" TraitType="Disease" MappingType="XRef" MappingValue="C1306856" MappingRef="MedGen">
        <MedGen CUI="C4551825" Name="Imerslund-Grasbeck syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25211" TraitType="Disease" MappingType="Name" MappingValue="IMERSLUND-GRASBECK SYNDROME 2" MappingRef="Preferred">
        <MedGen CUI="C4016948" Name="Imerslund-Grasbeck syndrome type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

